KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Income from Non-Controlling Interests (2017 - 2020)

Historic Income from Non-Controlling Interests for Ionis Pharmaceuticals (IONS) over the last 5 years, with Q4 2020 value amounting to -$1.2 million.

  • Ionis Pharmaceuticals' Income from Non-Controlling Interests fell 10591.03% to -$1.2 million in Q4 2020 from the same period last year, while for Sep 2021 it was -$1.2 million, marking a year-over-year increase of 9218.7%. This contributed to the annual value of -$35.5 million for FY2020, which is 48920.58% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Income from Non-Controlling Interests of -$1.2 million as of Q4 2020, which was down 10591.03% from -$12.1 million recorded in Q3 2020.
  • Over the past 5 years, Ionis Pharmaceuticals' Income from Non-Controlling Interests peaked at $19.5 million during Q4 2019, and registered a low of -$17.3 million during Q4 2018.
  • Its 4-year average for Income from Non-Controlling Interests is -$6.9 million, with a median of -$9.3 million in 2018.
  • In the last 5 years, Ionis Pharmaceuticals' Income from Non-Controlling Interests skyrocketed by 21267.3% in 2019 and then crashed by 25919.89% in 2020.
  • Over the past 4 years, Ionis Pharmaceuticals' Income from Non-Controlling Interests (Quarter) stood at -$6.2 million in 2017, then plummeted by 177.64% to -$17.3 million in 2018, then soared by 212.67% to $19.5 million in 2019, then tumbled by 105.91% to -$1.2 million in 2020.
  • Its Income from Non-Controlling Interests was -$1.2 million in Q4 2020, compared to -$12.1 million in Q3 2020 and -$11.9 million in Q2 2020.